Lurbinectedin + Doxorubicin In Leiomyosarcoma

Clinical trial NCT05099666 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05099666
Sponsor: Massachusetts General Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Soft-tissue Sarcoma Metastatic Soft-tissue Sarcoma Advanced Leiomyosarcoma Leiomyosarcoma Metastatic

Start date: 2022-02-04
Primary completion: 2026-07-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.